Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/21/2002 | US20020022274 Masking background fluorescence and luminescence in optical analysis of biomedical assays |
02/21/2002 | US20020022271 Nutrient broth for the preservaton of blood during analysis |
02/21/2002 | US20020022269 Hematology composition using preserved white blood cells in combination with source particles to simulate native white blood cells and method of making same |
02/21/2002 | US20020022259 Cardiac-cell specific enhancer elements and uses thereof |
02/21/2002 | US20020022257 Three-dimensional structure and crystallization method of ribosome recycling factor (RRF) |
02/21/2002 | US20020022254 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
02/21/2002 | US20020022250 Process for pan-genomic determination of macromolecular atomic structures |
02/21/2002 | US20020022247 Microplate for drug susceptibility testing and testing method |
02/21/2002 | US20020022245 Method of identifying compounds suitable for treatment and/or prophylaxis of obesity |
02/21/2002 | US20020022244 Assessment of oxidant stress in vitro and in vivo |
02/21/2002 | US20020022242 Detection of preferential nervous system disorder; obtain sample of body fluid, detect preferential enzyme with adjusted glycosylation pattern |
02/21/2002 | US20020022241 Detecting preferential immunoglobulins in solution; provide solid support, immoblize squalene on support, wash with blocking agent, incubate with test sample, incubate with ligand, incubate with indicator, detect indicator |
02/21/2002 | US20020022240 Method of assessing the biological status of cancer development |
02/21/2002 | US20020022239 Fluorescent adducts comprising an apoprotein and a bilin (e.g. apophytochrome-phycoerythrobilin adducts); intensely fluorescent, photostable proteins useful as probes for biological research |
02/21/2002 | US20020022238 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins |
02/21/2002 | US20020022237 Encoding metal salts are impregnated onto the support unit, with isotope distribution of the metal in the salt used as code; insoluble metal salts are formed to improve metal's retention |
02/21/2002 | US20020022236 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
02/21/2002 | US20020022235 Monitoring immunotherapeutic activities; measure antibody concentration of human, incubate human with xenogenic antibody, monitor concentration of antibodies, amplified levels of antibodies indicates effective therapy |
02/21/2002 | US20020022234 That is antigenic and useful for forming antibodies having utility in standardizing diagnostic assays, comprising a lysine component, an arginine component and a reducing sugar component |
02/21/2002 | US20020022233 Screening a library of small organic compound to identify those having affinity for a particular site on a biomolecular target, by forming a covalent bond with a chemically reactive group at that site |
02/21/2002 | US20020022232 Computing fittings between sample nucleic acid and control; generate indicators, compute transformational adjustments, determine possible conformational patterns |
02/21/2002 | US20020022230 Compositions and methods for directly and rapidly analyzing the biochemical components of microorganisms |
02/21/2002 | US20020022229 Detecting genetic disorder; obtain sample, detect bone morphogenic protein mutation, the presence of mutation indicates genetic disorder |
02/21/2002 | US20020022226 Method and device for detecting hybridization reaction |
02/21/2002 | US20020022223 Screening for target nucleotide sequences; join oligonucleotide probes to electronic leads, incubate with target nucleotide sequences, hybridize, apply eletrical current, leads carring current indicates bound target |
02/21/2002 | US20020022222 Method of preparing a standard diagnostic gene transcript pattern |
02/21/2002 | US20020022220 Counting cyclic-adenosine monophosphate in cells; provide cells, remove nutrients, mix cells with cyclic-adenosine monophosphate recovery solution, incubate, concentrate solution, count cyclic-adenosine monophosphate in solution |
02/21/2002 | US20020022218 Methods for the identification of compounds useful for the treatment of disease states medicated by prostaglandin D2 |
02/21/2002 | US20020022217 High density streptavidin supports |
02/21/2002 | US20020022053 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto |
02/21/2002 | US20020022033 Diagnosis of Aids |
02/21/2002 | US20020022023 Treatment of diabetes mellitus and insulin receptor signal transduction |
02/21/2002 | US20020021984 In combustion exhaust gases by flame ionization |
02/21/2002 | US20020021299 Method for displaying results of hybridization experiment |
02/21/2002 | US20020020670 Apparatus for parallel high-performance liquid chromatography with serial injection |
02/21/2002 | US20020020632 Membrane based electrochemical test device and related methods |
02/21/2002 | US20020020276 Pathology grossing board |
02/21/2002 | US20020020224 Sheet-like strain sensor for confirming progress of damage of concrete structure and method for confirming progress of damage of concrete structure |
02/21/2002 | US20020020215 Apparatus and method to obtain representative samples of oil well production |
02/21/2002 | US20020020210 Gas sensor |
02/21/2002 | US20020020208 Instrument for combustible gas detection |
02/21/2002 | US20020020206 Optical sensor and method of operation |
02/21/2002 | DE10129489A1 Bewertungsmethode für polykristallines Silizium Evaluation method for polycrystalline silicon |
02/21/2002 | DE10111224A1 Analoge der Ecstasy-Klasse sowie Verwendung derselben beim Nachweis von Verbindungen der Ecstasy-Klasse Analog ecstasy-class and use thereof in the detection of compounds of ecstasy-class |
02/21/2002 | DE10058416C1 Determination of oxygen content of interstitial water in formations containing sediment and clay comprises feeding protective tube into formation, feeding sensor into tube and sucking water through inlet in protective tube over sensor |
02/21/2002 | DE10057832C1 Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample |
02/21/2002 | DE10041263A1 Determining chemical impurities in gases using gas-sensitive semiconducting layers involves influencing electrical properties of layers in connection with adsorbed or absorbed materials |
02/21/2002 | DE10039229A1 Device for measuring and/or monitoring parameters of water in body of water comprises measuring head and evaluating device coupled via wireless data transmission device |
02/21/2002 | DE10038382A1 Zweifarbiges fluorimetrisches Proteaseassay Two-toned fluorometric protease assay |
02/21/2002 | DE10025384A1 Quantitative Messung von Molekülmengen im komplexen Gemischen Quantitative measurement of molecular quantities in complex mixtures |
02/21/2002 | DE10025379A1 Bestimmung von NAALADase-Inhibitoren Determination of NAALADase inhibitors |
02/21/2002 | CA2420006A1 Lipo- or amphiphilic scintillators and their use in assays |
02/21/2002 | CA2419985A1 Modulating multiple lineage kinase proteins |
02/21/2002 | CA2419555A1 Fish hatching method and apparatus |
02/21/2002 | CA2419551A1 Assay method and device for detecting the presence and concentration of analytes |
02/21/2002 | CA2419544A1 Pathways arrays |
02/21/2002 | CA2419543A1 Wide-range toc instrument using plasma oxidation |
02/21/2002 | CA2419529A1 Diagnosis and treatment of tumor-suppressor associated disorders |
02/21/2002 | CA2419491A1 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
02/21/2002 | CA2419474A1 Bioreactor and bioprocessing technique |
02/21/2002 | CA2419425A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
02/21/2002 | CA2419392A1 Method for preparation of chewing gum with customer acceptable taste |
02/21/2002 | CA2419159A1 Ultra-sensitive detection systems |
02/21/2002 | CA2419128A1 Apparatus and methods for measuring extensional rheological properties of a material |
02/21/2002 | CA2419126A1 Basecalling system and protocol |
02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
02/21/2002 | CA2418861A1 Method and device for characterising and/or for detecting a bonding complex |
02/21/2002 | CA2418735A1 Mass spectrometry |
02/21/2002 | CA2418725A1 Claudin polypeptides |
02/21/2002 | CA2418320A1 The anti-neoplastic agent et-743 inhibits trans activation by sxr |
02/21/2002 | CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
02/21/2002 | CA2418087A1 Use of microbial dna sequences for the identification of human diseases |
02/21/2002 | CA2417986A1 Single-labeled oligonucleotide probes |
02/21/2002 | CA2417844A1 Acetylation of prb by p300 and assay methods for compounds which modulate this process |
02/21/2002 | CA2417141A1 Novel glycoproteins and methods of use thereof |
02/21/2002 | CA2417088A1 Methods and molecules useful for identifying molecules that bind lfa-1 and for determining receptor occupancy |
02/21/2002 | CA2415353A1 Use of antibodies against specific mhc-peptide complexes |
02/20/2002 | EP1180687A1 Method and in vitro kit for selecting a drug for chemotherapy |
02/20/2002 | EP1180686A1 Remedies for kidney diseases and method for screening the same |
02/20/2002 | EP1180685A1 Apparatus for quantitatively determining water content and base number |
02/20/2002 | EP1180684A1 High estrogen-sensitive medaka fish |
02/20/2002 | EP1180678A2 Method for testing a cell sample |
02/20/2002 | EP1180677A2 A method and a system for determination of particles in a liquid sample |
02/20/2002 | EP1180676A2 A method and a system for determination of particles in a liquid sample |
02/20/2002 | EP1180675A2 A method and a system for determination of particles in a liquid sample |
02/20/2002 | EP1180549A1 Method of measuring polymorphism |
02/20/2002 | EP1180525A1 Transcriptional activation inhibitory protein |
02/20/2002 | EP1180244A2 High troughput assay systems and methods |
02/20/2002 | EP1180242A1 Vesicle containing polymers and sensor detection methods based thereon |
02/20/2002 | EP1180241A1 Method of detecting and quantifying endotoxins |
02/20/2002 | EP1180240A1 Process for utilizing epitopes recognized by natural antibodies |
02/20/2002 | EP1180239A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
02/20/2002 | EP1180238A1 Device and method for isolating electrically charged molecules |
02/20/2002 | EP1180169A1 Methods of detecting polynucleotide kinase and its use as a label |
02/20/2002 | EP1180165A2 A nematode drug screen for modulators of mammalian disorders |
02/20/2002 | EP1180162A2 An apparatus for the analysis of the electrophysiology of neuronal cells and its use in high-throughput functional genomics |
02/20/2002 | EP1180151A2 Protein kinases |
02/20/2002 | EP1180147A1 Secreted alpha-helical protein-31 |
02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |